References

Click on [Link] to connect to abstract or full text

1. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. Journal of leukocyte biology 2005; 78: 819-35. [Link]

2. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB Journal 2002; 16: 1335-47. [Link]

3. Febbraio MA, Pedersen BK. Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exercise and sport sciences reviews 2005; 33: 114-9. [Link]

4. Bastard J-P, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. European cytokine network 2006; 17: 4-12. [Link]

5. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004; 110: 1564-71. [Link]

6. Das UN. Is obesity an inflammatory condition? Nutrition 2001; 17: 953-66. [Link]

7. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. The British journal of nutrition 2004; 92: 347-55. [Link]

8. Florez H, Castillo-Florez S, Mendez A, Casanova-Romero P, Larreal-Urdaneta C, Lee D, et al. C-reactive protein is elevated in obese patients with the metabolic syndrome. Diabetes research and clinical practice 2006; 71: 92-100. [Link]

9. Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Annals of internal medicine 2000; 132: 605-11. [Link]

10. Calder PC, Kew S. The immune system: a target for functional foods? The British journal of nutrition 2002; 88 Suppl 2: S165-77. [Link]

11. Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, et al. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes care 1997; 20: 545-50. [Link]

12. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA : the journal of the American Medical Association 1997; 277: 472-7. [Link]

13. Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. The American journal of clinical nutrition 2002; 75: 492-8. [Link]

14. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & pharmacotherapy 2002; 56: 365-79. [Link]

15. Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F, et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. The Journal of clinical endocrinology and metabolism 2006; 91: 439-46. [Link]

16. Ambring A, Johansson M, Axelsen M, Gan L, Strandvik B, Friberg P. Mediterranean-inspired diet lowers the ratio of serum phospholipid n-6 to n-3 fatty acids, the number of leukocytes and platelets, and vascular endothelial growth factor in healthy subjects. The American journal of clinical nutrition 2006; 83: 575-81. [Link]

17. Jonasson T, Ohlin A-K, Gottsater A, Hultberg Br, Ohlin H. Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation. Clinical chemistry and laboratory medicine 2005; 43: 628-34. [Link]

18. Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes care 2005; 28: 1438-44. [Link]

19. Rodreguez-Herna¡ndez H, Gonzalez JL, Rodreguez-Moran M, Guerrero-Romero F. Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis in obese subjects. Archives of medical research 2005; 36: 362-6. [Link]

20. King DE, Mainous AG, Geesey ME, Woolson RF. Dietary magnesium and C-reactive protein levels. Journal of the American College of Nutrition 2005; 24: 166-71. [Link]

21. Bernardini D, Nasulewic A, Mazur A, Maier JAM. Magnesium and microvascular endothelial cells: a role in inflammation and angiogenesis. Frontiers in bioscience : a journal and virtual library 2005; 10: 1177-82. [Link]

22. Ford ES, Giles WH, Mokdad AH, Ajani UA. Microalbuminuria and concentrations of antioxidants among US adults. American journal of kidney diseases : the official journal of the National Kidney Foundation 2005; 45: 248-55. [Link]

23. Accinni R, Rosina M, Bamonti F, Della Noce C, Tonini A, Bernacchi F, et al. Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects. Nutrition, metabolism, and cardiovascular diseases 2006; 16: 121-7. [Link]

24. Kaperonis EA, Liapis CD, Kakisis JD, Dimitroulis D, Papavassiliou VG, Perrea D, et al. Inflammation and chlamydia pneumoniae infection correlate with the severity of peripheral arterial disease. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2006; 31: 509-15. [Link]

25. Kuppuswamy VC, Gupta S. Antibiotic therapy for coronary heart disease: the myth and the reality. Timely topics in medicine Cardiovascular diseases [electronic resource] 2006; 10: E2. [Link]

26. Corrado E, Rizzo M, Tantillo R, Muratori I, Bonura F, Vitale G, et al. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke; a journal of cerebral circulation 2006; 37: 482-6. [Link]

27. Fernandez-Real J-M, Lopez-Bermejo A, Vendrell J, Ferri M-J, Recasens Mn, Ricart W. Burden of infection and insulin resistance in healthy middle-aged men. Diabetes care 2006; 29: 1058-64. [Link]

28. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine 2005; 352: 1685-95. [Link]

29. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA : the journal of the American Medical Association 2001; 286: 327-34. [Link]

30. Spranger J, Kroke A, Mohlik M, Hoffmann K, Bergmann MM, Ristow M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003; 52: 812-7. [Link]

31. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes care 2005; 28: 1769-78. [Link]

32. Barzilay J, Freedland E. Inflammation and its association with glucose disorders and cardiovascular disease. Treatments in endocrinology 2003; 2: 85-94. [Link]

33. Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Current problems in cardiology 2004; 29: 439-93. [Link]

34. Verma S, Szmitko PE, Ridker PM. C-reactive protein comes of age. National clinical and practical cardiovascular medicine 2005; 2: 29-36. [Link]

35. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003; 168: 351-8. [Link]

36. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA : the journal of the American Medical Association 2002; 287: 356-9. [Link]

37. Cankurtaran M, Halil M, Yavuz BB, Dagli N, Oyan B, Ariogul S. Prevalence and correlates of metabolic syndrome (MS) in older adults. Archives of gerontology and geriatrics 2006; 42: 35-45. [Link]

38. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-8. [Link]

39. Woods JA. Exercise and resistance to neoplasia. Canadian journal of physiology and pharmacology 1998; 76: 581-8. [Link]

40. Bruunsgaard H, Pedersen BK. Special feature for the Olympics: effects of exercise on the immune system: effects of exercise on the immune system in the elderly population. Immunology and cell biology 2000; 78: 523-31. [Link]

41. Yan H, Kuroiwa A, Tanaka H, Shindo M, Kiyonaga A, Nagayama A. Effect of moderate exercise on immune senescence in men. European journal of applied physiology 2001; 86: 105-11. [Link]

42. Smith TP, Kennedy SL, Fleshner M. Influence of age and physical activity on the primary in vivo antibody and T cell-mediated responses in men. Journal of applied physiology: respiratory and exercise physiology 2004; 97: 491-8. [Link]

43. Drela N, Kozdron E, Szczypiorski P. Moderate exercise may attenuate some aspects of immunosenescence. BMC Geriatrics 2004; 4: 1-7. [Link]

44. Shinkai S, Konishi M, Shephard RJ. Aging and immune response to exercise. Canadian journal of physiology and pharmacology 1998; 76: 562-72. [Link]

45. Lemmey A, Maddison P, Breslin A, Cassar P, Hasso N, McCann R, et al. Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritis. The Journal of rheumatology 2001; 28: 29-34. [Link]

46. de Jong Z, Munneke M, Lems WF, Zwinderman AH, Kroon HM, Pauwels EKJ, et al. Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: results of a randomized, controlled trial. Arthritis and rheumatism 2004; 50: 1066-76. [Link]

47. Meksawan K, Venkatraman JT, Awad AB, Pendergast DR. Effect of dietary fat intake and exercise on inflammatory mediators of the immune system in sedentary men and women. Journal of the American College of Nutrition 2004; 23: 331-40. [Link]

48. Rexrode KM, Pradhan A, Manson JE, Buring JE, Ridker PM. Relationship of total and abdominal adiposity with CRP and IL-6 in women. Annals of epidemiology 2003; 13: 674-82. [Link]

49. Petersen AMW, Pedersen BK. The anti-inflammatory effect of exercise. Journal of applied physiology: respiratory and exercise physiology 2005; 98: 1154-62. [Link]

50. Buyukyazi G, Kutukculer N, Kutlu N, Genel F, Karadeniz G, Ozkutuk N. Differences in the cellular and humoral immune system between middle-aged men with different intensity and duration of physically training. The Journal of sports medicine and physical fitness 2004; 44: 207-14. [Link]

51. Wang J-S, Huang Y-H. Effects of exercise intensity on lymphocyte apoptosis induced by oxidative stress in men. European journal of applied physiology 2005; 95: 290-7. [Link]

52. Sato Y, Nanri H, Ohta M, Kasai H, Ikeda M. Increase of human MTH1 and decrease of 8-hydroxydeoxyguanosine in leukocyte DNA by acute and chronic exercise in healthy male subjects. Biochemical and biophysical research communications 2003; 305: 333-8. [Link]

53. Mackinnon LT. Chronic exercise training effects on immune function. Medicine and science in sports and exercise 2000; 32: S369-76. [Link]

54. Nieman DC. Is infection risk linked to exercise workload? Medicine and science in sports and exercise 2000; 32: S406-11. [Link]

55. Nieman DC. Special feature for the Olympics: effects of exercise on the immune system: exercise effects on systemic immunity. Immunology and cell biology 2000; 78: 496-501. [Link]

56. Bruunsgaard H, Ladelund S, Pedersen AN, Schroll M, Jorgensen T, Pedersen BK. Predicting death from TNF-a and IL-6 in 80-year-old people. Clinical & experimental immunology 2003; 132: 24-31. [Link]

57. Panagiotakos DB, Pitsavos C, Chrysohoou C, Kavouras S, Stefanadis C, Study A. The associations between leisure-time physical activity and inflammatory and coagulation markers related to cardiovascular disease: the ATTICA Study. Preventive medicine 2005; 40: 432-7. [Link]

58. Colbert LH, Visser M, Simonsick EM, Tracy RP, Newman AB, Kritchevsky SB, et al. Physical activity, exercise, and inflammatory markers in older adults: findings from the health, aging, and body composition study. Journal of american geriatric society 2004; 52: 1098-104. [Link]

59. King DE, Carek P, Mainous III AG, Pearson WS. Inflammatory markers and exercise: differences related to exercise type. Medicine and science in sports and exercise 2003; 35: 575-81. [Link]

60. Reuben DB, Judd-Hamilton L, Harris TB, Seeman TE. The associations between physical activity and inflammatory markers in high-functioning older persions: MacArthur studies of successful aging. Journal of american geriatric society 2003; 51: 1125-30. [Link]

61. Jankord R, Jemiolo B. Influence of physical activity on serum IL-6 and IL-10 levels in healthy older men. Medicine and science in sports and exercise 2004; 36: 960-4. [Link]

62. Bruun JM, Helge JrW, Richelsen Br, Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. American journal of physiology Endocrinology and metabolism 2006; 290: E961-7. [Link]

63. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767-72. [Link]

64. Robinson LE, Graham TE. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity. Canadian journal of applied physiology 2004; 29: 808-29. [Link]

65. Obisesan TO, Leeuwenburgh C, Phillips T, Ferrell RE, Phares DA, Prior SJ, et al. C-reactive protein genotypes affect baseline, but not exercise training-induced changes, in C-reactive protein levels. Arteriosclerosis, Thromosis and vascular biology 2004; 24: 1874-9. [Link]

66. Lakka TA, Lakka H-M, Rankinen T, Leon AS, Rao DC, Skinner JS, et al. Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE Family Study. European heart journal 2005; 26: 2018-25. [Link]

67. Larsen AI, Aukrust P, Aarsland T, Dickstein K. Effect of aerobic exercise training on plasma levels of tumor necrosis factor alpha in patients with heart failure. The American journal of cardiology 2001; 88: 805-8. [Link]

68. Tisi PV, Hulse M, Chulakadabba A, Gosling P, Shearman CP. Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 1997; 14: 344-50. [Link]

69. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA : the journal of the American Medical Association 2002; 288: 980-7. [Link]

70. Stauffer BL, Hoetzer GL, Smith DT, DeSouza CA. Plasma C-reactive protein is not elevated in physically active postmenopausal women taking hormone replacement therapy. Journal of applied physiology: respiratory and exercise physiology 2004 96: 143-8. [Link]

71. Wei M, Schwerter HA, Blair SN. The association between physical activity, physical fitness, and type 2 diabetes mellitus. Comprehensive therapy 2000; 26: 176-82. [Link]

72. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 2001; 50: 2384-9. [Link]

73. Duncan BB, Schmidt MIs, Pankow JS, Ballantyne CM, Couper D, Vigo A, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003; 52: 1799-805. [Link]

74. Ryan AS, Nicklas BJ. Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes care 2004; 27: 1699-705. [Link]

75. McGavock JM, Mandic S, Vonder Muhll I, Lewanczuk RZ, Quinney HA, Taylor DA, et al. Low cardiorespiratory fitness is associated with elevated C-reactive protein levels in women with type 2 diabetes. Diabetes care 2004; 27: 320-5. [Link]

[Top]